Monday, 28 May 2018

You are here

The RheumNow Week in Review – 28 October 2016

Dr. Jack Cush reviews highlights, news and journal reports from this week at RheumNow.com

  1. A persistant limp in a child is the most common early sign of juvenile arthritis. http://buff.ly/2eDouyw
  2. Hydroxychloroquine hearing loss/ototoxicity - a rare complication that I did not know about! https://t.co/W4JM6mbTKW
  3. Twos tudies suggest RA is associated with 1.5-2 fold increased risk of hearing loss. https://t.co/qMLNbfFdre https://t.co/Kafe628jUI
  4. Panel of neutrophil genes may be highly predictive of TNFi response in RA pts; CMPK2, IFIT1B, and RNASE3 https://t.co/4jjaHdgGgQ
  5. Comparing TB vs Pyogenic spondylitis:TB spondylitis has more extraspinal findings, Hx TB, +IGRA; also more fever, abscess (psoas,vert) https://t.co/IeKPQDY6M9
  6. In Ireland, Pfizer has cut the price of Enbrel to match the price of Benepali - an ETN biosimilar. https://t.co/AKdp5bhHoc
  7. J&J will compete w/ price of Inflectra through a variety of innovative contracting options, discounts & rebates to payers, providers, & PBMs
  8. Rheumatoid nodules almost never ulcerate; but gout tophi DO! Risk factors age, tophus size & no protective sensation https://t.co/kmsnNlRBF2
  9. Everything will be alright in the end; & if it’s not alright, then it’s not yet the end. Dr. Cush blogs on “Prescribing Hope in Medicine” https://t.co/7CHXGJBuuA
  10. Metanalysis 3 RCTs shows starting allopurinol during acute gout attack does not increase pain or prolong attack. https://t.co/XU6CQxBTNU
  11. RA Blacks usually have less Xray erosions; new study shows PAD4/PAD3 Abs found in African-Americans w/ Xray severity https://t.co/CDpUQDbLfa
  12. 5 big Methotrexate Mistakes: Such as taking MTX : 1) daily (instead of weekly); 2) without Folate daily; 3) with renal failure, 4) without routine labs; abd 5) with HBsAg+
  13. Type I diabetes is often assoc w/ other autoimmune Dz, includying Hashimotos, celiac sprue, Graves, RA, vitiligo https://t.co/CHWK3fuXOK
  14. The POSTURE Study finds that Apremilast Fails in Ankylosing Spondylitis. http://rheumnow.com/content/posture-study-apremilast-fails-ankylosing-sp...
  15. Metanalysis of simultaneous versus staged bilateral total knee arthroplasty http://rheumnow.com/content/simultaneous-versus-staged-bilateral-total-k...
  16. Kawasaki Disease Pathogenesis Hinges on Interleukin-1 . New finding that a polymorphism in the inositol-triphosphate 3-kinase C leads to increased NLRP3 inflammasome activity and excess IL-1 in KD patients.
    http://rheumnow.com/content/kawasaki-disease-pathogenesis-hinges-interle...
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

I enjoy your website RheumNow and your weekly highlights. Old guys like me need to be "spoon-fed". In regards to mistakes with methotrexate, I have 2 concerns: 1. Many people are being characterized as having CKD based on automated chemistry. Calculated GFR's and CrCls indicate stages 1-4. At what point should I be concerned about methotrexate toxicity? Should I get serum or red cell methotrexate levels or use any of the other testing for methotrexate toxicity available commercially such as 5,10-Methylenetetrahydrofolate reductase (MTHFR) ? Is there a "standard of care" in the setting of CKD? 2. Please note that the likelihood of methotrexate toxicity in greatly increased when a patient is admitted to a SNF or other long term care situation where weekly meds are unusual. The staff may change qweekly to qdaily because they think there is a typo error. David S. Knapp, MD (semi-retired)

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.